Skip to content
logo-dark
  • Home
  • Updates
  • Social Platform
  • Login
  • Home
  • Updates
  • Social Platform

Blog - Science on demand - Page 2

  1. Home
  2. Blogs
  3. Page 2
FDA-Approved Antisense Oligonucleotide Therapies for Duchenne Muscular Dystrophy
  • Orevan
  • September 28, 2026
  • Rare Disease

FDA-Approved Antisense Oligonucleotide Therapies for Duchenne Muscular Dystrophy

Introduction Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy and is an X-linked recessive genetic disorder caused by deficiency of dystrophin. The DMD gene is located on Xp21, […]

Read More
Evaluation of Dietary Management and Monitoring Practices in Pharmaceutical Clinical Trials for Inborn Errors of Metabolism
  • Orevan
  • September 23, 2026
  • Rare Disease

Evaluation of Dietary Management and Monitoring Practices in Pharmaceutical Clinical Trials for Inborn Errors of Metabolism

Background Inborn errors of metabolism (IEMs) are rare genetic disorders caused by loss or deficiency of important enzymatic functions. This can result in accumulation of toxic substances, disruption of metabolic […]

Read More
The gut microbiome as a therapeutic potential for inborn errors of metabolism disorders
  • Orevan
  • September 21, 2026
  • Rare Disease

The gut microbiome as a therapeutic potential for inborn errors of metabolism disorders

1. Overview Inborn errors of metabolism (IEMs) are monogenic inherited disorders caused by defects in specific metabolic enzymes or proteins. These defects interfere with normal biochemical pathways and can result […]

Read More
Gene Therapy for Duchenne Muscular Dystrophy
  • Orevan
  • September 16, 2026
  • Rare Disease

Gene Therapy for Duchenne Muscular Dystrophy

1. Overview Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular disorder caused by variants in the DMD gene, located on chromosome Xp21. It affects approximately 1 in 6,000 live male […]

Read More
Fabry disease cardiomyopathy: A state-of-the-art review
  • Orevan
  • September 14, 2026
  • Rare Disease

Fabry disease cardiomyopathy: A state-of-the-art review

1. Overview Fabry disease (FD) is an X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene, resulting in deficient activity of the lysosomal enzyme α-galactosidase A (α-Gal […]

Read More
The Diagnosis and Therapy of Osteoporosis in Gaucher Disease
  • Orevan
  • September 9, 2026
  • Rare Disease

The Diagnosis and Therapy of Osteoporosis in Gaucher Disease

Abstract Gaucher disease (GD) is a rare lysosomal storage disorder caused by a deficiency of the enzyme acid β-glucosidase, which leads to the buildup of glucocerebroside lipids in different organs. […]

Read More
Fabry Disease: Updated Perspective and Review of Treatment and Therapies
  • Orevan
  • September 7, 2026
  • Rare Disease

Fabry Disease: Updated Perspective and Review of Treatment and Therapies

1. Overview of Fabry Disease Fabry disease (FD) is a progressive, multisystemic, X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene. These variants lead to reduced or […]

Read More
  • Orevan
  • September 7, 2026
  • Rare Disease

Fabry Disease: Updated Perspective and Review of Treatment and Therapies

1. Overview of Fabry Disease Fabry disease (FD) is a progressive, multisystemic, X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene. These variants lead to reduced or […]

Read More
Global Considerations for Lifelong Management and Therapeutic Development for Phenylketonuria (PKU)
  • Orevan
  • September 2, 2026
  • Rare Disease

Global Considerations for Lifelong Management and Therapeutic Development for Phenylketonuria (PKU)

intrduction Phenylketonuria (PKU) is an autosomal recessive inherited metabolic disorder caused by pathogenic variants in the PAH gene, which encodes phenylalanine hydroxylase (PAH). PAH, together with its cofactor tetrahydrobiopterin (BH4), […]

Read More
Coordination of Care in Gaucher Disease Type I
  • Orevan
  • August 26, 2026
  • Rare Disease

Coordination of Care in Gaucher Disease Type I

Coordination of Care in Gaucher Disease Type I 1. Principles of Coordinated Care Care coordination provides a structured approach to managing the complex medical and non-medical needs of patients with […]

Read More
  • 1
  • 2
  • 3

Asides

Sorting
Filtered (28)
Filters
  • Reset all×
  • Rare Disease×

28 posts found

Search
×
Categories
Date
Apply(28) Reset
Show (28)
Cancel
Apply(28) Reset
post-img
November 2, 2026
Gaucher Disease: State of the Art and Perspectives
post-img
October 28, 2026
Care Needs of Children with Inborn Errors of Metabolism (IEMs) and Their Parents
post-img
October 26, 2026
Gaucher Disease Type 3 from Infancy Through Adulthood: A Conceptual Model of Signs, Symptoms, and Impacts Associated with Ataxia and Cognitive Impairment
banner

Feel free to reach us anytime. we are avaliable 24 hours

Contact Us
logo-dark

Download app from

app-storeplay-store
Help
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
Inquiry Email
science-ondemand@orevan.org
© 2026 SCIENCE ON DEMAND. All Rights Reserved.
People Who like this post
  • img
img